Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Oncology Today with Dr Neil Love
00:00
When to Switch from TDXD to Maintenance
Hope outlines decisions for patients with prolonged TDXD response and using endocrine therapy plus palbociclib or tucatinib.
Play episode from 25:59
Transcript
